These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

586 related articles for article (PubMed ID: 33148014)

  • 21. Comparison of prognostic impact of anticoagulants in heart failure patients with atrial fibrillation and renal dysfunction: direct oral anticoagulants versus vitamin K antagonists.
    Sakai T; Motoki H; Fuchida A; Takeuchi T; Otagiri K; Kanai M; Kimura K; Minamisawa M; Yoshie K; Saigusa T; Ebisawa S; Okada A; Kitabayashi H; Kuwahara K
    Heart Vessels; 2022 Jul; 37(7):1232-1241. PubMed ID: 35064298
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Direct Oral Anticoagulants Compared with Vitamin K Antagonists for Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
    Fang S; Zhu BZ; Yang F; Wang Z; Xiang Q; Gong YJ
    Curr Pharm Des; 2022; 28(23):1902-1910. PubMed ID: 35400334
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A mixed methodology, non-interventional study to evaluate the use of direct oral anticoagulants in UK clinical practice for patients with a first stroke associated with non-valvular atrial fibrillation: study protocol.
    Bhat Y; Dixit A; Mistri A; Patel B; Quoraishi SH; Uprichard J
    BMC Neurol; 2019 Nov; 19(1):306. PubMed ID: 31783738
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Efficacy and Safety of Direct Oral Anticoagulants Versus Vitamin K Antagonists in the Treatment of Left Ventricular Thrombus: A Systematic Review and Meta-analysis.
    Burmeister C; Beran A; Mhanna M; Ghazaleh S; Tomcho JC; Maqsood A; Sajdeya O; Assaly R
    Am J Ther; 2021 Apr; 28(4):e411-e419. PubMed ID: 33852473
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Safety and Efficacy of Novel Oral Anticoagulants Versus Warfarin in Medicare Beneficiaries With Atrial Fibrillation and Valvular Heart Disease.
    Briasoulis A; Inampudi C; Akintoye E; Alvarez P; Panaich S; Vaughan-Sarrazin M
    J Am Heart Assoc; 2018 Apr; 7(8):. PubMed ID: 29622591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long-term outcome of chronic thromboembolic pulmonary hypertension using direct oral anticoagulants and warfarin: a Japanese prospective cohort study.
    Hosokawa K; Abe K; Funakoshi K; Tamura Y; Nakashima N; Todaka K; Taniguchi Y; Inami T; Adachi S; Tsujino I; Yamashita J; Minatsuki S; Ikeda N; Shimokawahara H; Kawakami T; Ogo T; Hatano M; Ogino H; Fukumoto Y; Tanabe N; Matsubara H; Fukuda K; Tatsumi K; Tsutsui H
    J Thromb Haemost; 2023 Aug; 21(8):2151-2162. PubMed ID: 37044277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prescription Patterns and Outcomes of Patients With Atrial Fibrillation Treated With Direct Oral Anticoagulants and Warfarin: A Real-World Analysis.
    Kattoor AJ; Pothineni NV; Goel A; Syed M; Syed S; Paydak H; Mehta JL
    J Cardiovasc Pharmacol Ther; 2019 Sep; 24(5):428-434. PubMed ID: 31035795
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Off-Label Under- and Overdosing of Direct Oral Anticoagulants in Patients With Atrial Fibrillation: A Meta-Analysis.
    Zhang XL; Zhang XW; Wang TY; Wang HW; Chen Z; Xu B; Xu W
    Circ Cardiovasc Qual Outcomes; 2021 Dec; 14(12):e007971. PubMed ID: 34932377
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Use of Direct Oral Anticoagulants in Morbidly Obese Patients.
    Kido K; Lee JC; Hellwig T; Gulseth MP
    Pharmacotherapy; 2020 Jan; 40(1):72-83. PubMed ID: 31834939
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment Failures of Direct Oral Anticoagulants.
    Kajy M; Mathew A; Ramappa P
    Am J Ther; 2021 Jan-Feb 01; 28(1):e87-e95. PubMed ID: 31599766
    [TBL] [Abstract][Full Text] [Related]  

  • 31. When Direct Oral Anticoagulants Should Not Be Standard Treatment: JACC State-of-the-Art Review.
    Bejjani A; Khairani CD; Assi A; Piazza G; Sadeghipour P; Talasaz AH; Fanikos J; Connors JM; Siegal DM; Barnes GD; Martin KA; Angiolillo DJ; Kleindorfer D; Monreal M; Jimenez D; Middeldorp S; Elkind MSV; Ruff CT; Goldhaber SZ; Krumholz HM; Mehran R; Cushman M; Eikelboom JW; Lip GYH; Weitz JI; Lopes RD; Bikdeli B
    J Am Coll Cardiol; 2024 Jan; 83(3):444-465. PubMed ID: 38233019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of Prescribing Practices and Outcomes Using Direct-acting Oral Anticoagulants After Cardiac Surgery.
    Kanaan DM; Cook BM; Kelly J; Malloy R
    Clin Ther; 2021 Jun; 43(6):e209-e216. PubMed ID: 34078556
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A review of indications and comorbidities in which warfarin may be the preferred oral anticoagulant.
    Wadsworth D; Sullivan E; Jacky T; Sprague T; Feinman H; Kim J
    J Clin Pharm Ther; 2021 Jun; 46(3):560-570. PubMed ID: 33393699
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Efficacy of Direct Acting Oral Anticoagulant Drugs in Treatment of Left Atrial Appendage Thrombus in Patients With Atrial Fibrillation.
    Fleddermann A; Eckert R; Muskala P; Hayes C; Magalski A; Main ML
    Am J Cardiol; 2019 Jan; 123(1):57-62. PubMed ID: 30376957
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparing the Efficacy and Safety of Direct Oral Anticoagulants With Warfarin in the Morbidly Obese Population With Atrial Fibrillation.
    Kido K; Ngorsuraches S
    Ann Pharmacother; 2019 Feb; 53(2):165-170. PubMed ID: 30130979
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Trends of anticoagulant use and outcomes of patients with non-valvular atrial fibrillation: Findings from the RAFFINE registry.
    Miyazaki S; Miyauchi K; Hayashi H; Yamashiro K; Tanaka R; Nishizaki Y; Nojiri S; Suwa S; Sumiyoshi M; Nakazato Y; Urabe T; Hattori N; Minamino T; Daida H
    J Cardiol; 2022 Jul; 80(1):41-48. PubMed ID: 35346556
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Suboptimal Use of Oral Anticoagulants in Atrial Fibrillation: Has the Introduction of Direct Oral Anticoagulants Improved Prescribing Practices?
    Alamneh EA; Chalmers L; Bereznicki LR
    Am J Cardiovasc Drugs; 2016 Jun; 16(3):183-200. PubMed ID: 26862063
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Real-world incidence of efficacy and safety outcomes in patients on direct oral anticoagulants with left ventricular systolic dysfunction at a tertiary referral center.
    Tseng AS; William Schleifer J; Shen WK; McBane R; Mankad S; Esser H; Vucicevic D; Shamoun FE
    Clin Cardiol; 2017 Dec; 40(12):1328-1332. PubMed ID: 29247519
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Direct oral anticoagulants versus warfarin in nonvalvular atrial fibrillation patients with prior gastrointestinal bleeding: a network meta-analysis of real-world data.
    Hu W; Cai H; Zhang J
    Eur J Clin Pharmacol; 2022 Jul; 78(7):1057-1067. PubMed ID: 35296907
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Safety and Effectiveness of Direct Oral Anticoagulants Versus Warfarin for Treating Left Ventricular Thrombus.
    Herald J; Goitia J; Duan L; Chen A; Lee MS
    Am J Cardiovasc Drugs; 2022 Jul; 22(4):437-444. PubMed ID: 35352321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.